FIRST DAY
Wednesday September 27th
13.25-13.30 pm - Opening
Welcome and introduction:
Pr Eric Deutsch,
Director of Gustave Roussy Radiation Oncology Department and INSERM UMR 1030
PRIMER ON CANCER IMMUNOLOGY, RADIATIONS AND IMMUNOTHERAPY
Educational Session
13.30-15.30 Part I
13.30-14.00: INNATE IMMUNITY
Tumor-associated macrophages from bench to bedside,
Pr Alberto Mantovani, Istituto Clinico Humanitas, IT
14.00-14.30: ADAPTIVE IMMUNITY
Role of tertiary lymphoid structures in response to anti-cancer immunotherapy,
Pr Antoine Italiano, Gustave Roussy, FR
14.30-15.00: IMMUNOLOGICAL CELL DEATH
Immunological cell death: inducers and enhancers,
Pr Guido Kroemer, Cordeliers Research Center, FR
15.00-15.30: ABSCOPAL EFFECT
Mechanisms of interaction of radiotherapy with immunotherapy,
Pr Silvia Formenti, Weill Cornell Medicine, USA
15.30-16.00 Coffee break
16.00-18.00 Part II
16.00-16.30: CLINICAL IMMUNOTHERAPY
How to build on the top of current chemo-radiations and PD-L1 inhibitors? The NSCLC model,
Pr Fabrice Barlési, Gustave Roussy, FR
16.30-17.00: DNA DAMAGE RESPONSE
Modulating DNA damage responses to enhance radiotherapy-immunotherapy combinations,
Pr Kevin Harrington, Institute of Cancer Research, UK
17.00-17.30: RADIO-IMMUNOTHERAPY
Immunogenic cell death driven by radiotherapy – Mechanisms and implications,
Dr Lorenzo Galluzzi, Weill Cornell Medicine, USA
MAIN PROGRAM
Keynote Presentation
17.30-18.15: AI for Cancer Precision Medicine,
Pr Fabrice André, Gustave Roussy, FR
18.00-20.00 COCKTAIL POSTER SESSION
